Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC-NDJournal of Allergy and Clinical Immunology

Molecular engineering of a therapeutic antibody for Blo t 5–induced allergic asthma

Abstract

Epidemiological studies have established a causal link between sensitization to house dust mite (HDM) allergens and the development of allergic asthma. Despite the coexistence of the 2 major dust mite species in the tropics and dual sensitization profiles in atopic individuals, IgE responses targeting Blomia tropicalis have limited cross-reactivity with Dermatophagoides pteronyssinus.1 Among all known allergens of B tropicalis, Blo t 5 is the principal sensitizing allergen in tropical countries.

Related

  1. Special Issue: Molecular Therapeutic Strategies in Allergic Diseases
    Emilia Majsiak, Natalia Łępa, Sylwia Smolinska-Wilczynska
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0ImmunologyCrossref
  2. Molecular engineering of lysosome-based degraders unveils a rapidly expanding therapeutic strategy
    Adele Rivault, Jade Dussart-Gautheret, Rachid Benhida +4
    AutophagyPeer-reviewedCC BY 4.0Full text4 citedCell biologyMedicinal chemistry & drug discoveryHAL
  3. Molecular Signatures of HIV-Induced Neuroinflammation and Neurodegeneration in Human Cerebral Organoids: Identification of Therapeutic Targets for NeuroHIV.
    Karthick Chennakesavan, Malaroviyam Samikkannu, Shreyan Gupta +5
    Advanced science (Weinheim, Baden-Wurttemberg, Germany)Peer-reviewedCC BYFull textMicrobiologyEurope PMC
  4. Stem cell factor in allergic diseases: mechanisms of type 2 immunity and therapeutic opportunities
    Ramon Ocadiz-Ruiz, Sarita Montaño, Nicholas W. Lukacs +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  5. Mutation-induced structural and dynamic perturbations at the IL-17A–IL-17RA interface: Therapeutic insights from multi-replicate molecular dynamics simulations
    Afsheen Razzaq, Madiha Sardar, Mamona Mushtaq +3
    PLOS OnePeer-reviewedCC BY 4.0Proteomics & metabolomicsBioinformatics & computational biologyPLOS
BibTeX
@article{chan2026molecular,
  title = {{Molecular engineering of a therapeutic antibody for Blo t 5–induced allergic asthma}},
  author = {J.H. Sherlynn Chan and Yen Leong Chua and Hong Yong Peh and Vojislav Jovanovic and Nicholas R.J. Gascoigne and W. Wong and Fook Tim Chew and Brendon Hanson and David Kemeny and Paul Macary},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jaci.2016.10.028},
  url = {https://hal.science/hal-05787795v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Molecular engineering of a therapeutic antibody for Blo t 5–induced allergic asthma
AU  - J.H. Sherlynn Chan
AU  - Yen Leong Chua
AU  - Hong Yong Peh
AU  - Vojislav Jovanovic
AU  - Nicholas R.J. Gascoigne
AU  - W. Wong
AU  - Fook Tim Chew
AU  - Brendon Hanson
AU  - David Kemeny
AU  - Paul Macary
PY  - 2026
DA  - 2026/10/09
JO  - Journal of Allergy and Clinical Immunology
DO  - 10.1016/j.jaci.2016.10.028
UR  - https://hal.science/hal-05787795v1
AB  - Epidemiological studies have established a causal link between sensitization to house dust mite (HDM) allergens and the development of allergic asthma. Despite the coexistence of the 2 major dust mite species in the tropics and dual sensitization profiles in atopic individuals, IgE responses targeting Blomia tropicalis have limited cross-reactivity with Dermatophagoides pteronyssinus.1 Among all known allergens of B tropicalis, Blo t 5 is the principal sensitizing allergen in tropical countries.
SN  - 0091-6749
ER  -